Tokio Marine Asset Management Co. Ltd. Has $996,000 Holdings in Aflac Incorporated (NYSE:AFL)

Tokio Marine Asset Management Co. Ltd. grew its position in Aflac Incorporated (NYSE:AFL) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,075 shares of the financial services provider’s stock after purchasing an additional 779 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Aflac were worth $996,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of AFL. Morgan Stanley increased its position in Aflac by 9.0% in the 3rd quarter. Morgan Stanley now owns 9,643,531 shares of the financial services provider’s stock worth $740,141,000 after purchasing an additional 794,784 shares during the last quarter. QRG Capital Management Inc. acquired a new position in shares of Aflac during the 3rd quarter valued at about $47,492,000. Vanguard Group Inc. increased its holdings in shares of Aflac by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 54,208,007 shares of the financial services provider’s stock valued at $4,160,465,000 after acquiring an additional 605,210 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of Aflac by 8,861.1% during the 4th quarter. International Assets Investment Management LLC now owns 449,849 shares of the financial services provider’s stock valued at $37,113,000 after acquiring an additional 444,829 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Aflac by 5.3% during the 3rd quarter. Northern Trust Corp now owns 7,295,810 shares of the financial services provider’s stock valued at $559,953,000 after acquiring an additional 368,704 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Price Performance

Shares of AFL stock opened at $83.58 on Friday. The stock has a 50 day moving average of $82.69 and a two-hundred day moving average of $81.75. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 12 month low of $64.10 and a 12 month high of $86.26. The company has a market capitalization of $48.09 billion, a P/E ratio of 10.78, a P/E/G ratio of 2.31 and a beta of 0.91.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter in the prior year, the business posted $1.29 EPS. As a group, equities analysts expect that Aflac Incorporated will post 6.41 EPS for the current year.

Wall Street Analysts Forecast Growth

AFL has been the topic of a number of analyst reports. Raymond James increased their price objective on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and increased their price objective for the company from $76.00 to $78.00 in a report on Thursday, January 4th. UBS Group increased their price objective on Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, January 10th. Wells Fargo & Company decreased their target price on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research note on Thursday, April 11th. Finally, Keefe, Bruyette & Woods increased their target price on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $82.15.

Insider Buying and Selling

In related news, Director Thomas J. Kenny sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Thomas J. Kenny sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the transaction, the director now owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The disclosure for this sale can be found here. Insiders sold 46,493 shares of company stock worth $3,765,706 in the last 90 days. 0.90% of the stock is owned by company insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.